Leavell Investment Management’s Bio-Techne TECH Stock Holding History

Leavell Investment Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.59M	Sell	36,590 -3,038	-8%	-$164K	0.09%	199
2026 Q1	$2.07M	Sell	39,628 -500	-1%	-$30K	0.08%	215
2025 Q4	$2.36M	Sell	40,128 -800	-2%	-$48.6K	0.1%	197
2025 Q3	$2.28M	Sell	40,928 -3,069	-7%	-$164K	0.1%	205
2025 Q2	$2.26M	Sell	43,997 -2,360	-5%	-$119K	0.1%	194
2025 Q1	$2.72M	Sell	46,357 -2,000	-4%	-$136K	0.13%	161
2024 Q4	$3.48M	Sell	48,357 -800	-2%	-$58.7K	0.17%	136
2024 Q3	$3.93M	Hold	49,157	–	–	0.2%	119
2024 Q2	$3.52M	Sell	49,157 -2,900	-6%	-$213K	0.19%	117
2024 Q1	$3.66M	Sell	52,057 -12,187	-19%	-$872K	0.21%	110
2023 Q4	$4.96M	Sell	64,244 -4,720	-7%	-$311K	0.32%	84
2023 Q3	$4.69M	Sell	68,964 -5,100	-7%	-$403K	0.33%	76
2023 Q2	$6.05M	Sell	74,064 -700	-0.9%	-$56.3K	0.41%	67
2023 Q1	$5.55M	Sell	74,764 -6,900	-8%	-$532K	0.4%	69
2022 Q4	$6.77M	Sell	81,664 -700	-0.8%	-$55.6K	0.51%	58
2022 Q3	$5.85M	Sell	82,364 -200	-0.2%	-$17.3K	0.46%	62
2022 Q2	$7.16M	Hold	82,564	–	–	0.55%	56
2022 Q1	$8.94M	Buy	82,564 +40	+0%	+$4.13K	0.61%	49
2021 Q4	$10.7M	Sell	82,524 -1,400	-2%	-$172K	0.71%	36
2021 Q3	$10.2M	Buy	83,924 +2,120	+3%	+$258K	0.76%	36
2021 Q2	$7.81M	Hold	81,804	–	–	0.64%	47
2021 Q1	$7.81M	Buy	81,804 +1,000	+1%	+$91.2K	0.64%	47
2020 Q4	$6.42M	Hold	80,804	–	–	0.55%	55
2020 Q3	$5M	Buy	80,804 +1,400	+2%	+$91.1K	0.43%	62
2020 Q2	$5.24M	Buy	79,404 +9,600	+14%	+$575K	0.51%	62
2020 Q1	$3.31M	Sell	69,804 -2,000	-3%	-$100K	0.38%	80
2019 Q4	$3.94M	Hold	71,804	–	–	0.37%	83
2019 Q3	$3.51M	Hold	71,804	–	–	0.36%	87
2019 Q2	$3.74M	Buy	71,804 +400	+0.6%	+$20.2K	0.39%	76
2019 Q1	$3.54M	Hold	71,404	–	–	0.4%	80
2018 Q4	$2.58M	Hold	71,404	–	–	0.32%	94
2018 Q3	$3.64M	Sell	71,404 -400	-0.6%	-$17.7K	0.39%	76
2018 Q2	$2.66M	Hold	71,804	–	–	0.3%	96
2018 Q1	$2.71M	Hold	71,804	–	–	0.32%	98
2017 Q4	$2.33M	Hold	71,804	–	–	0.27%	110
2017 Q3	$2.17M	Buy	71,804 +2,000	+3%	+$59.4K	0.27%	109
2017 Q2	$2.05M	Hold	69,804	–	–	0.26%	108
2017 Q1	$1.77M	Hold	69,804	–	–	0.23%	115
2016 Q4	$1.79M	Hold	69,804	–	–	0.25%	106
2016 Q3	$1.91M	Hold	69,804	–	–	0.28%	106
2016 Q2	$1.97M	Sell	69,804 -10,000	-13%	-$257K	0.29%	101
2016 Q1	$1.89M	Sell	79,804 -1,600	-2%	-$35.2K	0.28%	101
2015 Q4	$1.83M	Hold	81,404	–	–	0.27%	101
2015 Q3	$1.88M	Hold	81,404	–	–	0.3%	97
2015 Q2	$2M	Hold	81,404	–	–	0.31%	98
2015 Q1	$2.04M	Hold	81,404	–	–	0.31%	101
2014 Q4	$1.88M	Hold	81,404	–	–	0.29%	108
2014 Q3	$1.9M	Sell	81,404 -2,000	-2%	-$46.9K	0.3%	104
2014 Q2	$1.93M	Hold	83,404	–	–	0.31%	105
2014 Q1	$1.78M	Buy	83,404 +2,000	+2%	+$45K	0.3%	105
2013 Q4	$1.93M	Hold	81,404	–	–	0.33%	94
2013 Q3	$1.63M	Buy	81,404 +3,000	+4%	+$56.9K	0.29%	93
2013 Q2	$1.35M	Buy	+78,404	New	+$1.3M	0.25%	108

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Leavell Investment Management's TECH Position: Q2 2026 in Review

Leavell Investment Management reduced its Bio-Techne (TECH) stake by 7.7% in Q2 2026, selling an estimated $164K and leaving 36,590 shares worth $2.59M. The position accounts for 0.09% of the portfolio, ranked #199.

Leavell Investment Management first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.7M in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Leavell Investment Management held 36,590 shares of Bio-Techne worth $2.59M as of Q2 2026.
Leavell Investment Management sold 3,038 Bio-Techne shares in Q2 2026, an estimated $164K.
Bio-Techne made up 0.09% of Leavell Investment Management's portfolio in Q2 2026, its #199 holding.
Leavell Investment Management first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
Leavell Investment Management's Bio-Techne position peaked at $10.7M in Q4 2021.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.